Reliance Life Sciences Pvt. Ltd. is an Indian pharmaceutical company with its headquarters in Navi Mumbai, Maharashtra, India. The company was set up under the Dhirubhai Ambani Group in the year 2001. It was incorporated on the 30th of January in the year 2001. The company forms a part of the Promoter Group of Reliance Industries Limited. The company was mainly set up in order to generate trade options in the field of biotechnology with a focus on biopharmaceuticals, regenerative medicines, clinical research and molecular diagnostics. The Reliance Group could see that in the 21st century, biotechnology was appearing as a profitable entity. With this in mind, they incepted the company and the cell biology facility in the year 2001 with a capital investment of five million dollars. Reliance Life Sciences made collaboration with the biggest global thyroid testing laboratory called Thyrocare Technologies in order to provide genetic testing services based on DNA technology to the people of country. The company has the biggest number of biosimilars in the market and has launched five biosimilars which are the first in the world. The company is also in the process of developing the largest amount of biosimilars in the entire world. The company is the first one to manufacture plasma proteins in the whole of South Asia. It has sped up the production of regenerative medicine in India. It is also the most experienced company in the entire country when it comes to the area of cord blood stem cell transplants. The company is a non-profitable organization.

The company develops trade options in the field of bio-therapeutics, oncology, stem cells therapies like cord blood stem cell transplant, clinical research and molecular diagnostics.

Reliance Life Sciences Pvt. Ltd. operates through its multiple manufacturing facilities located in India at Rabale in Navi Mumbai. Dhirubhai Ambani Life Sciences Centre is one of the best life sciences campuses across the world. The facilities operate according to global standards and have received approval from major regulatory bodies. The company has a dense operation network.

Some of the top products of the company are ALBUREL, TRASTUREL, IMMUNOREL, RITUXIREL, MIREL, BEVACIREL, RELICITABINE, TENECTEREL, ABCIXIREL, RELITREXED, DARBEREL, LOREL, RELIGRAST, TERLIREL, RELIBETA, TEMOREL, ASHPI, KLOZA, OLAPAX, DXT, ZINCORIL-L, LIV-L, REXICAM, RELICALM-CD, RELIFEN PLUS, R-FLOX, HEMOREL-A, PERIDON PLUS, FLUTINE, R-ZEP, BROMEX-A, QUTIN, NICETAM, OPTRA-OZ, TRAZARIL, RELIDOMIDE, EFOSPAR, R-MOX CV, PANTARIL, NEUROTONE PLUS, MANSEX, RELISEAL, R-KAST-L, LITHORIL, CERRATA PLUS, IMATIREL, ROMECID-D, EPIPHEN, ZENERIL and CIPORIL-PLUS.